GlassScriptPhysician profile
Oliver Peter Favalli
NPI 1598874752
$2,721.52
in general payments reported to CMS, 2019-2025
9 companies · $1,093 in 2025
The $1,093 reported for 2025 was more than what 97% of Pediatric Dentistry providers received nationally (typical 2025 total: $42.86).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.01 · 2020: $174 · 2021: $387 · 2022: $646 · 2023: $246 · 2024: $111 · 2025: $1,093.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $931 · Education: $350 · Gift: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $931.28 |
| Education | $350.00 |
| Gift | $168.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $2,139.21 | 2020-2025 | Invisalign, Itero Element 5d Plus Lite |
| World Class Technology Corporation | $184.61 | 2019-2025 | Pitts21, Pitts21 Pro |
| Ultradent Products INC | $168.53 | 2023 | Opalescence |
| 3m Company | $124.70 | 2020-2022 | |
| Patterson Companies, INC. | $35.36 | 2025 | |
| Envista Holdings Corporation | $17.83 | 2025 | Spark |
| Ormco Corporation | $17.68 | 2022 | |
| Biolase, INC. | $17.32 | 2019 | |
| Dentsply Sirona INC | $16.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oliver Favalli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.